GMP IPO Watch logo GMP IPO Watch
Exchange Traded Funds (ETFs) - Equity ETF

Aditya Birla Sun Life Nifty Healthcare ETF

Aditya Birla Sun Life Mutual Fund

Risk: Very High Risk
52W Low ₹14.14 29 Jan 2026 52W High ₹17.91 9 Nov 2026
₹17.7331 NAV as of 13 Nov 2026 -0.38% day change
ISININF209KB10C2
Scheme Code149262
StructureOpen Ended Schemes
Fund HouseAditya Birla Sun Life AMC Limited
AUM (avg. July - September 2026)₹81.44 Cr
Expense Ratio (as of 12 Nov 2026)0.22%
Min. Investment₹500
Inception Date8 Oct 2021
BenchmarkNifty Healthcare TRI · NA
Portfolio Turnover87.39%
NFO Period2021-10-08T00:00:00.000 – 2021-10-20T00:00:00.000

Returns

1Y +16.74%
3Y +21.33%
5Y +15.42%
Since Inception +15.23%

Annualised (CAGR) returns for periods over a year.

Want to invest in this fund?

Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.

Open Free Account

Rank in Category

PeriodThis FundCategory Avg.Rank
1W +1.80% +1.31% 31 of 86
1M +8.66% +6.90% 36 of 82
3M +3.90% +0.31% 17 of 73
6M +12.71% +6.66% 16 of 63
YTD +18.33% +2.33% 2 of 86
1Y +16.74% +2.18% 2 of 55
2Y +11.68% +6.71% 7 of 45
3Y +21.33% +13.84% 5 of 35
5Y +15.42% +10.51% 4 of 24
INCEPTION +15.23% — —

Ranked among: Exchange Traded Funds (ETFs) - Equity ETF.

Rolling Returns

PeriodAverageBestWorstPositive PeriodsConsistency
3M +3.92% +24.05% -13.94% 65% 26%
6M +8.31% +32.66% -15.39% 69% 29%
1Y +19.09% +63.65% -12.16% 85% 38%
2Y +21.89% +38.60% +2.87% 100% 47%
3Y +21.71% +27.31% +15.62% 100% 48%
5Y +14.66% +15.77% +13.20% 100% 46%

Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.

NAV History

AUM Trend (₹ Cr, quarterly average)

Expense Ratio Trend

Portfolio · Oct 2026

Asset Allocation

  • Equity99.99%
  • Debt0.00%
  • Cash0.01%
  • Other0.00%

Market Cap Split

  • Large Cap47.26%
  • Mid Cap48.97%
  • Small Cap3.76%
  • Others0.01%

Fundamentals

FundCategory
P/E41.46—
P/B5.38—
Price / Sales5.68—
Price / Cash Flow30.77—
Dividend Yield (%)0.60—
Holdings20
Top 5 Stocks49.91%
Top 10 Stocks76.34%
Top 3 Sectors99.99%

Holdings · Oct 2026

HoldingSectorWeightChange (1M)
Sun Pharmaceutical Pharmaceuticals & Biotechnology 16.32% -0.68%
Divis Laboratories Pharmaceuticals & Biotechnology 10.78% +0.32%
Laurus Labs Pharmaceuticals & Biotechnology 8.12% +1.31%
Apollo Hospitals Equity 7.54% +0.09%
Dr Reddys Laboratories Pharmaceuticals & Biotechnology 7.15% +0.51%
Cipla Pharmaceuticals & Biotechnology 6.73% +0.04%
Torrent Pharmaceuticals Pharmaceuticals & Biotechnology 5.89% -0.37%
Max Healthcare Institute Equity 5.55% -0.56%
Lupin Pharmaceuticals & Biotechnology 4.23% -0.12%
Aurobindo Pharma Pharmaceuticals & Biotechnology 4.03% -0.05%
Fortis Healthcare Equity 3.47% -0.07%
Glenmark Pharmaceuticals Pharmaceuticals & Biotechnology 3.00% -0.10%
Alkem Laboratories Pharmaceuticals & Biotechnology 2.68% -0.09%
Zydus Life Science Pharmaceuticals & Biotechnology 2.68% +0.14%
Mankind Pharma Pharmaceuticals & Biotechnology 2.45% -0.05%
View all 22 holdings
IPCA Laboratories Pharmaceuticals & Biotechnology 2.32% -0.04%
Gland Pharma Pharmaceuticals & Biotechnology 2.14% +0.10%
Biocon Pharmaceuticals & Biotechnology 2.13% -0.15%
Krishna Institute of Medical Sciences Equity 1.62% -0.14%
Abbott Pharmaceuticals & Biotechnology 1.16% -0.06%
TREPS Reverse Repo / TREPS 0.25% —
Net Receivable / Payable Net Current Assets -0.24% —

Sector Allocation · Oct 2026

Risk Metrics

Standard Deviation

PeriodFundCategory
1Y 14.31 18.45 Low Volatility
3Y 14.83 17.13 Low Volatility
5Y 14.99 16.77 Low Volatility
What is this?

Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.

Sharpe Ratio

PeriodFundCategory
1Y 0.50 -0.41 Above Average
3Y 0.97 -0.94 Above Average
5Y 0.59 0.30 Above Average
What is this?

Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.64% (published 2026-11-06).

Sortino Ratio

PeriodFundCategory
1Y 1.80 0.29 Above Average
3Y 2.07 1.23 Above Average
5Y 1.55 0.98 Above Average
What is this?

Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.

Beta

PeriodFundCategory
1Y 0.95 0.96 Good Risk Adjusted Returns
3Y 0.99 0.96 Poor Risk Adjusted Returns
5Y 0.99 0.95 Poor Risk Adjusted Returns
What is this?

This value gives idea about how volatile fund performance has been compared to similar funds in the market. Lower beta implies the fund gives more predictable performance compared to similar funds in the market.

Tracking Difference

1Y-0.22%
3Y-0.05%
5Y-0.06%
Since Inception-0.08%

Versus Nifty Healthcare TRI, as of Oct 2026.

Compare With Peers

Scheme 1Y3Y5YSince Inception
Mirae Asset Nifty Metal ETF
+20.35% — — +11.85%
Axis NIFTY Healthcare ETF
+16.53% +20.93% +15.09% +14.39%
Mirae Asset Nifty PSU Bank ETF
+12.06% — — +17.21%
Kotak Nifty PSU Bank ETF
+11.73% +21.58% +26.61% +6.12%
Mirae Asset S&P 500 Top 50 ETF
+10.78% +24.72% +16.54% +18.09%
Zerodha CASE Nifty Smallcap 100 ETF
Direct Plan
+8.92% — — +8.65%
Aditya Birla Sun Life Silver ETF
+8.01% +35.39% — +24.24%
Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETF
+7.69% — — +3.13%
Aditya Birla Sun Life Gold ETF
+6.75% +30.33% +21.62% +11.42%
Mirae Asset Nifty MidSmallcap400 Momentum Quality 100 ETF
+5.86% — — +2.60%

More From Aditya Birla Sun Life AMC Limited

Scheme 1Y3Y5YSince Inception
Aditya Birla Sun Life Pharma and Healthcare Fund
Direct Plan · GROWTH
+19.68% +20.70% +15.88% +21.21%
Aditya Birla Sun Life Manufacturing Equity Fund
Direct Plan · GROWTH
+17.97% +20.87% +15.03% +13.32%
Aditya Birla Sun Life Transportation and Logistics Fund
Direct Plan · IDCW
+17.85% — — +22.57%
Aditya Birla Sun Life US Equity Passive FOF
Direct Plan · GROWTH
+17.25% +26.46% +16.87% +16.49%
Aditya Birla Sun Life Small Cap Fund
Direct Plan · GROWTH
+15.92% +15.20% +13.30% +16.82%
Aditya Birla Sun Life Infrastructure Fund
Direct Plan · GROWTH
+14.22% +17.91% +17.04% +15.62%
Aditya Birla Sun Life Global Excellence Equity Fund Of Fund
Direct plan · IDCW
+13.95% +20.01% +11.94% +9.07%
Aditya Birla Sun Life International Equity Fund
Direct Plan · GROWTH
+13.10% +21.02% +10.93% +11.64%
Aditya Birla Sun Life Retirement Fund-The 30s Plan
Direct Plan · GROWTH
+13.06% +17.53% +11.96% +13.18%
Aditya Birla Sun Life Nifty Smallcap 50 Index Fund
Direct Plan · IDCW
+13.03% +16.48% +12.97% +17.00%

About This Scheme

Investment Objective

The investment objective of the scheme is to provide returns that before expenses, closely correspond to the total returns of securities as represented by Nifty Healthcare TRI, subject to tracking errors. However, the performance of scheme may differ from that of the underlying index due to tracking error.

Stated Asset Allocation

Under normal circumstances, the asset allocation of the Scheme will be as follows: Equity & Equity related instruments constituting Nifty Healthcare TRI - 95 to 100% - Medium to High Cash, Money Market & Debt instruments - 0 to 5% - Low

Exit Load

NIL

Fund Managers

Mr. Mehul Dama

Comanage

Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.

Market Open · Closes 3:30 PM
NSE BSE NFO BFO CDS BCD MCX NSCOM